Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
08/2003
08/05/2003US6602827 Herbicidal 5-chlorodifluoromethyl-1,3,4-thiadiazol-2-yl-oxyacetanilides
08/05/2003CA2275827C Method for treating glaucoma
07/2003
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/31/2003US20030144260 Heterocyclic compounds, method of developing new drug leads and combinatorial libraries used in such method
07/24/2003WO2003059897A1 Thiadiazole compounds and use thereof
07/24/2003WO2003059876A2 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
07/24/2003US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/23/2003EP1187819B1 N-substituted perhydro diazine
07/23/2003EP0877741B1 Acylated 5-amino-1,2,4-thiadiazoles as pesticides and fungicides
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
07/16/2003EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003US20030130320 Alpha 4 integrin antagonists
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/10/2003CA2471049A1 Amide derivatives as gk activators
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/08/2003US6589915 The invention relates to cyclohexenone derivatives of benzo-condensed, unsaturated 5-ring nitrogen heterocycles of general formula (I) wherein X represents N or a group C-R3, Y represents O, S, SO, SO2 or NR4 or X-Y represent S
07/03/2003WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053978A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053947A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471120A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/02/2003EP1322674A2 Control agents for living-type free radical polymerization, methods of polymerizing, emulsions and polymers with same
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
07/02/2003CN1113061C Synthesis of 2-(methyl sulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole
07/02/2003CN1112849C Use of 1,2,3-thiadiazole carboxylic acid (thio) esters of control of pests
07/01/2003US6586466 Carbohydrazide-protease inhibitors
06/2003
06/26/2003WO2003051854A1 Thiadiazoline derivative
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051325A1 Skin lightening agents, novel compounds, compositions and use
06/26/2003US20030119936 Making by photopolymerization of a reactive mesogen having a photopolymerizable endgroup, such as a diene; intermediate 2,7-bis(5-(4-hydroxyphenyl)thien-2-yl)-9,9-dipropylfluorene
06/26/2003US20030119824 Treatment of inflammatory bowel disease
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119152 Substituted 2-amino-3- (2-amino-phenylsulfanyl) -propionic acids
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/18/2003EP1082297B1 Substituted dithio-bis-nitrobenzenes and their applications
06/17/2003US6579893 Related thiazolidinediones
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2190130C Thiadiazoles and their use as antipicornaviral agents
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/04/2003CN1421441A Hydrochlorothiazide refining process
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/29/2003US20030100551 Production of apoptotic films for direct contact with tumors
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6569969 Forming a mixture of one or more monomers, at least one free radical source and a control agent and subjecting mixture to polymerization conditions
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/22/2003WO2003042214A2 A2b adenosine receptor antagonists
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096848 Antiproliferative 1,2,3-thiadiazole compounds
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311490A1 Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same
05/21/2003EP1311264A1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/20/2003US6566390 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 100